← All candidates
One insider buy in the last year — $53.9K in all.
27 filings on record.
CLBCore Laboratories Inc. /DE/
NYSE · Energy · $573.56M
$12.50
-1.32% today
One insider buy in the last year — $53.9K in all.
Nothing in the last fortnight.
Price · 1Y · daily● 1 buy◆ 4 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$573.56M
Float
45.2M
99% public
Short % float
Pro
Price / profit
24.0
Price / future profit
17.8
Price / sales
1.1
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Chairman and CEO
Bruno Lawrence
Bought $53.9K on Jul 31 — 5,000 sh @ $10.78, held direct, 1.9% of their stake.
No completed positions to measure
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
22 more transactions on Pro →Context
Wall St
$15.50 avg target
+24.0% vs today · 3 analysts · consensus Hold
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
3 of 4 quarters beat
Q2 '26$0.11 act+$0.02
Q1 '26$0.06 act−$0.05
Q4 '25$0.21 act+$0.02
Q3 '25$0.22 act+$0.03
Coverage
CLB Q2 Deep Dive: Geopolitical Headwinds and Technology Adoption Shape ResultsStockStory · 08-04Is CLB Stock Attractive After Its Sharp Selloff and Mixed Q2 Results?Zacks · 07-31Core Laboratories Q2 Earnings Beat Estimates, Decline Y/YZacks · 07-31Core Laboratories Q2 Earnings Call HighlightsMarketBeat · 07-31
The file stays open
27 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice